Furthermore, expression of CREB3L1 is predictive of distant metastasis-free survival in patients with triple-negative breast cancer of the mesenchymal subtype, which is usually enriched for pathways associated with EMT (Supplementary Fig. 9)29. This evidence concerns the gene CREB3L1 and triple-negative breast carcinoma.